Тhe use of corticosteroids in patients with severe burn injuries
Abstract
Modern treatment of burns has led to a significant reduction in mortality in patients with burns whose injuries were fatal several years ago. However, along with improved survival, new problems arose in the treatment of burn patients. Systemic inflammatory response, capillary leak, sepsis top the list of the most common problems in both adults and children with severe thermal injury. Currently, new strategies are being developed and studied in the treatment of this category of patients. One of the ways to improve the results of treatment of patients with severe burn injury is to prescribe corticosteroids, both in the stage of burn shock and in the development of septic complications. Do corticosteroids reduce mortality and improve recovery in burn patients? The discussion about this has been going on for many years, but the opinion about their effectiveness remains controversial.
An analysis of the literature shows that corticosteroids can play a significant role in the treatment of patients with severe burn injury and can be successfully used at any stage of a burn disease. The effect of reducing capillary leakage, increasing myocardial contractility, antiemetic, membrane-stabilizing effect of corticosteroids will be useful in the stage of burn shock. The anti-inflammatory, immunomodulatory effect of corticosteroids will play a role in any stage of a burn disease. With the aim of preventing and treating sepsis, corticosteroids may be useful in the stage of toxemia, septicotoxemia. It is also necessary to remember about adrenal insufficiency, which develops in burn patients. The article analyzes the literature, substantiates the use of corticosteroids in patients with severe burn injury in different periods of a burn disease
Downloads
References
Marshall, W. J. (2002) St. Petersburg: “Publishing House BINOM”, Nevsky Dialect. Clinical biochemistry. 2nd ed. Per. from English. [in Russian]
Lavrov, V. A., Vinogradov, V. L. (2000) Burn shock: pathogenesis, clinic, treatment. Scientific Journal A.V. Vishnevsky Institute of Surgery, RAMS, 2, 1–5. [in Russian]
Becker, D. E. (2013). Basic and clinical pharmacology of glucocorticosteroids. Anesthesia progress, 60(1), 25–31. DOI: 10.2344/0003-3006-60.1.25
Schimmer, B. P., Funder, J. W. (2011) ACTH, adrenal steroids and pharmacology of the adrenal cortex. In: Brunton LL, Chabner BA, Knollmann BC, eds. Goodman and Gilman’s The Pharmacological Basis of Therapeutics. 12th ed. New York, NY: McGraw-Hill Companies Inc.
Stewart, P. M., Krone, N. P. (2011) The adrenal cortex. In: Melmed S, Polonsky KS, Larsen PR, Kronenberg HM, eds. Williams Textbook of Endocrinology. 12th ed. Philadelphia, Pa: Saunders Elsevier.
Hench, P. S., Kendall, E. C., Slocumb, C. H., & Polley, H. F. (1949). The effect of a hormone of the adrenal cortex (17-hydroxy-11-dehydrocorticosterone: compound E) and of pituitary adrenocortical hormone in arthritis: preliminary report. Annals of the rheumatic diseases, 8 (2), 97–104. DOI: 10.1136/ard.8.2.97
Rhen, T., Cidlowski, J. A. (2005) Antiinflammatory action of glucocorticoids--new mechanisms for old drugs. The New England Journal of Medicine, 353(16), 1711-1723. DOI: 10.1056/nejmra050541
Drogovoz, S. M., Strashny, V. V. (2002). Pharmacology to the rescue of the student, pharmacist and student. Kharkov, KhAI Publishing Center. [in Russian]
Lee, Y., Lin, Y. S. and Chen, Y. H. (2002). The effect of dexamethasone upon patient‐controlled analgesia‐related nausea and vomiting. Anaesthesia, 57, 705-709. DOI:10.1046/j.1365-2044.2002.02572_5.x
Sanchez, R. (2002). Initial shock from burns. Physiopathology: therapeutic principles. Pathol Biol (Paris), 50, 82–92. DOI: 10.1016/S0369-8114(01)00279-6
Winter, W., Kamolz, L., Donner, A., Hoerauf, K., Blaicher, A., Andel, H. (2003). Hydrocortisone improved haemodynamics and fluid requirement in surviving but not non-surviving of severely burned patients. Burns, 29(7), 717-20. DOI: 10.1016/s0305-4179(03)00148-7
Fuchs, PCh., Bozkurt, A., Johnen, D., Smeets, R., Groger, A., Pallua, N. (2007). Beneficial effect of corticosteroids in catecholamine-dependent septic burn patients. Burns, 33(3), 306-311. DOI: 10.1016/j.burns.2006.07.026]
Demling, R. H. (2005). The burn edema process: Current concepts. J Burn Care Rehab, 26(3), 207–227.
Kremer, T., Harenberg, P., Hernekamp, F., Riedel, K., Gebhardt, M. M., Germann, G., Heitmann, C., Walther, A. (2010). High-dose vitamin C treatment reduces capillary leakage after burn plasma transfer in rats. J Burn Care Res, 31(3), 470-479. DOI: 10.1097/BCR.0b013e3181db5199
Nabzdyk, C. S., Bittner, E. A. (2018). Vitamin C in the critically ill – lindications and controversies. World J Crit Care Med, 7(5), 52-61. DOI: 10.5492/wjccm.v7.i5.52
Endorf, F. W., Dries, D. J. (2011). Burn resuscitation. Scand J Trauma Resusc Emerg Med, 19, 32-41. DOI: 10.1186/1757-7241-19-69
Knabl, J. S., Bauer, W., Andel, H., Schwendenwein, I., Dado, P. F., Mittlböck, M., et al. (1999). Progression of burn wound depth by systemical application of a vasoconstrictor: an experimental study with a new rabbit model. Burns, 25(8), 715-721. DOI: 10.1016/s0305-4179(99)00086-8
Foldi, V., Lantos, J., Bogar, L., Roth, E., Weber, G., Csontos, C. (2010). Effects of fluid resuscitation methods on the pro- and anti-inflammatory cytokines and expression of adhesion molecules after burn injury. J Burn Care Res, 31(3), 480-491. DOI: 10.1097/BCR.0b013e3181db527a
Saffle, J. R. (2016). Fluid Creep and Over-resuscitation. Crit Care Clin, 32(4), 587-598. DOI: 10.1016/j.ccc.2016.06.007
Huang, G., Liang, B., Liu, G., Liu, K., Ding, Z. (2015). Low dose of glucocorticoid decreases the incidence of complications in severely burned patients by attenuating systemic inflammation. J Crit Care, 30(2), 436.e7-11. DOI: 10.1016/j.jcrc.2014.09.016
de Leeuw, K., Niemeijer, A. S., Eshuis, J., Nieuwenhuis, M. K., Beerthuizen, G. I., Janssen, W. M. (2016). Effect and mechanism of hydrocortisone on organ function in patients with severe burns. J Crit Care, 36, 200-206. DOI: 10.1016/j.jcrc.2016.06.007
Briegel, J., Jochum, M., Gippner-Steppert, C., Thiel, M. (2001). Immunomodulation in septic shock: Hydrocortisone differentially regulates cytokine responses. J Am Soc Nephrol, 17, 70-74.
Plassais, J., Venet, F., Cazalis, M. A., Le Quang, D., Pachot, A., Monneret, G., Tissot, S., Textoris, J. (2017). Transcriptome modulation by hydrocortisone in severe burn shock: ancillary analysis of a prospective randomized trial. Crit Care, 21(1), 158. DOI: 10.1186/s13054-017-1743-9
Janssen, WMT. (2017). Individualizing Optimal Fluid Resuscitation in Patients with Major Burns: Emerging Role for Hydrocortisone, Proteinuria and Brain Natriuretic Peptide. J Intensive & Crit Care, 3(3), 35. DOI: 10.21767/2471-8505.100094
Fuchs, PCh., Groge, A., Bozkurt, A., Johnen, D., Wolter, T., Pallua, N.. (2007). Cortisol in severely burned patients: investigations on disturbance of the hypothalamic-pituitary-adrenal axis. Shock, 28(6), 662-667.
Venet, F., Plassais, J., Textoris, J., Cazalis, M. A., Pachot, A., Bertin-Maghit, M., et al. (2015). Low-dose hydrocortisone reduces norepinephrine duration in severe burn patients: a randomized clinical trial. Crit Care, 26, 19-21. DOI: 10.1186/s13054-015-0740-0
Gayed, R., Weiss, A., Hodge, J., Ingram, W. (2019). Role of Hydrocortisone Therapy in Critically Ill Burn Patients with Hemodynamic Instability. Journal of Burn Care & Research, 40(1), 88–89. DOI: 10.1093/jbcr/irz013.145
Hoen, S., Mazoit, J-X., Asehnoune, K., Brailly-Tabard, S., Benhamou, D., Moine, P., Edouard, A. R. (2005). Hydrocortisone increases the sensitivity to alpha1-adrenoceptor stimulation in humans following hemorrhagic shock. Crit Care Med, 33(12), 2737–2743. DOI: 10.1097/01.ccm.0000189743.55352.0e
Walker, B. R/, Williams, B. C. (1992). Corticosteroids and vascular tone: mapping the messenger maze. Clin Sci Lond Engl, 82, 597–605. DOI: 10.1042/cs0820597
Reiff, D. A., Harkins, C. L., McGwin, G. Jr., Cross, J. M., Rue, L. W. 3rd. (2007). Risk factors associated with adrenal insufficiency in severely injured burn patients. J Burn Care Res, 28(6), 854-858. DOI: 10.1097/BCR.0b013e318159bfbb
Graves, K. K., Faraklas, I., Cochran, A. (2012). Identification of risk factors associated with critical illness related corticosteroid insufficiency in burn patients. J Burn Care Res, 33(3), 330-335. DOI: 10.1097/BCR.0b013e318239cc3d
Cooper, M. S., Bujalska, I., Rabbitt, E., Walker, E. A., Bland, R., Sheppard, M. C., Hewison, M., Stewart, P. M. (2001). Modulation of 11beta-hydroxysteroid dehydrogenase isozymes by proinflammatory cytokines in osteoblasts: an autocrine switch from glucocorticoid inactivation to activation. J Bone Miner Res, 16(6), 1037-1044. DOI: 10.1359/jbmr.2001.16.6.1037
Annane, D., Pastores, S. M., Rochwerg, B., Arlt, W., Balk, R. A., Beishuizen, A., Briegel, J., et al. (2017). Guidelines for the Diagnosis and Management of Critical Illness-Related Corticosteroid Insufficiency (CIRCI) in Critically Ill Patients (Part I): Society of Critical Care Medicine (SCCM) and European Society of Intensive Care Medicine (ESICM) 2017. Crit Care Med, 45(12), 2078-2088. DOI: 10.1097/CCM.0000000000002737
Sharma, B. R., Harish, D., Singh, V. P., Bangar, S. (2006). Septicemia as a cause of death in burns: an autopsy study. Burns, 32(5), 545-549. DOI: 10.1016/j.burns.2006.02.008
Williams, F. N., Herndon, D. N., Hawkins, H. K., Lee, J. O., Cox, R. A., Kulp, G. A., et al. (2009). The leading causes of death after burn injury in a single pediatric burn center. Crit Care, 13(6), R183. DOI: 10.1186/cc8170
Chipp, E., Milner, C. S., Blackburn, A. V. (2010). Sepsis in burns: a review of current practice and future therapies. Ann Plast Surg, 65(2), 228-36. DOI: 10.1097/SAP.0b013e3181c9c35c
D'Avignon, L. C., Hogan, B. K., Murray, C. K., Loo, F. L., Hospenthal, D. R., Cancio, L. C., Kim, S. H., Renz, E. M., Barillo, D., Holcomb, J. B., Wade, C. E., Wolf, S. E. (2010). Contribution of bacterial and viral infections to attributable mortality in patients with severe burns: an autopsy series. Burns, 36(6), 773-779. DOI: 10.1016/j.burns.2009.11.007
Schwacha, M. G. (2003). Macrophages and post-burn immune dysfunction. Burns, 29(1), 1-14. DOI: 10.1016/s0305-4179(02)00187-0
Girardot, T., Rimmelé, T., Venet, F., Monneret, G. (2017). Apoptosis-induced lymphopenia in sepsis and other severe injuries. Apoptosis, 22(2), 295-305. DOI: 10.1007/s10495-016-1325-3
Rygård, S. L., Butler, E., Granholm, A., Møller, M. H., Cohen, J., Finfer, S., Perner, A., Myburgh, J., Venkatesh, B., Delaney, A. (2018). Low-dose corticosteroids for adult patients with septic shock: a systematic review with meta-analysis and trial sequential analysis. Intensive Care Med, 44(7), 1003-1016. DOI: 10.1007/s00134-018-5197-6
Bellissant, E., Annane, D. (2000). Effect of hydrocortisone on phenylephrine–mean arterial pressure dose-response relationship in septic shock. Clin Pharmacol Ther, 68, 293-303. DOI: 10.1067/mcp.2000.109354
Annane, D., Sébille, V., Charpentier, C., Bollaert, P. E., François, B., Korach, J. M., Capellier, G., et al. (2002). Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA, 288, 862-871. doi: 10.1001/jama.288.7.862
Sherwin, R. L., Garcia, A. J., Bilkovski, R. (2012). Do low-dose corticosteroids improve mortality or shock reversal in patients with septic shock? A systematic review and position statement prepared for the American Academy of Emergency Medicine. J Emerg Med, 43(1), 7-12. DOI: 10.1016/j.jemermed.2011.08.015
Minneci, P. C., Deans, K. J., Eichacker, P. Q., Natanson, C. (2009). The effects of steroids during sepsis depend on dose and severity of illness: an updated meta-analysis. Clin Microbiol Infect, 15(4), 308-318. DOI: 10.1111/j.1469-0691.2009.02752.x
Sligl, W. I., Milner, Jr D. A., Sundar, S., Mphatswe, W., Majumdar, S. R. (2009). Safety and efficacy of corticosteroids for the treatment of septic shock: a systematic review and meta-analysis. Clin Infect Dis, 49(1), 93-101. doi: 10.1086/599343
Annane, D., Renault, A., Brun-Buisson, C., Megarbane, B., Quenot, J. P., Siami, S., Cariou, A., et al. (2018). Hydrocortisone plus Fludrocortisone for Adults with Septic Shock. N Engl J Med, 378(9), 809-818. DOI: 10.1056/NEJMoa1705716
Annane, D., Bellissant, E., Bollaert, P. E., Briegel, J., Keh, D., Kupfer, Y., Pirracchio, R., Rochwerg, B. (2019). Corticosteroids for treating sepsis in children and adults. Cochrane Database Syst Rev, 12, CD002243. DOI: 10.1002/14651858.CD002243.pub4
Sadaka, F., Grady, J., Organti, N., Donepudi, B., Korobey, M., Tannehill, D., O'Brien, J. (2019). Ascorbic Acid, Thiamine, and Steroids in Septic Shock: Propensity Matched Analysis. J Intensive Care Med, 17, 885066619864541. DOI: 10.1177/0885066619864541
Wald, E. L., Sanchez-Pinto, L. N., Smith, C. M., Moran, T., Badke, C. M., Barhight, M. F., Malakooti, M. R. (2020). Hydrocortisone-Ascorbic Acid-Thiamine Use Associated with Lower Mortality in Pediatric Septic Shock. Am J Respir Crit Care Med, 201(7), 863-867. DOI: 10.1164/rccm.201908-1543LE
